Call us now on: +44 (0) 1223 743170

Discovery STAR Award

Supporting Translational Academic Research

Domainex is committed to the support of exciting and cutting edge translational research. From its foundations out of The Institute of Cancer Research (ICR), Birkbeck College and UCL, to its on-going work with St George’s University, The University of Manchester and ICR; Domainex has exemplified how academic-private sector drug discovery collaborations can succeed and be beneficial to all parties.

See Eddy Littler, Domainex's CEO speaking about the first recipient of the Discovery STAR award


See further information about Domainex’s work in supporting
translational research

Domainex has therefore launched its Discovery STAR award, to support the early stages of drug discovery for a chosen number of applicants to the scheme. At Domainex’s discretion, selected applicants will then be provided with drug discovery advice and/or virtual hit screening 1 free of charge in order to prepare applicants for funding applications to schemes such as the Wellcome Trust SDDI, Technology Strategy Board, Biomedical Catalyst Fund or MRC DPFS 2.

Domainex will operate this scheme once a year. The next round deadline is shown below. If you have questions, please contact
Joanne McCudden at

In order to apply, please provide us with the following details:

STAR award applications: look out for announcement of new rounds in January 2014!

Academic Institute
Title of Project

Project summary

Please include brief information such as:

  • novelty of drug target or indication
  • are biochemical assays established to enable testing of the virtual hits identified in Domainex’s screen? Are these already established within the applicants laboratories? Please describe them.
  • is structural information of the target, its homologues or known ligand information available to enable a virtual screen to be completed? Please describe.
  • does the project address a significant unmet medical need?
  • do you have funding available to enable the purchase of 200-500 compounds from 3rd parties at £30/cpd? (see footnote 1)
  • what is your plan following successful hit identification, i.e. a wish to attract further funding to support a larger drug discovery project?
N.B. If you receive an error message after clicking submit, your application will not have been sent. In case of technical problems, please email your application to:

1 No compound purchase from 3rd parties is included and the cost of these must be found by the award recipient.

2 No cash alternatives to the award available.